Alfresa Holdings Corporation (TYO:2784)

Market Cap	461.11B +18.6%
Revenue (ttm)	3.06T +4.1%
Net Income	33.64B -2.2%
EPS	184.82 +0.3%
Shares Out	181.72M
PE Ratio	13.73
Forward PE	14.66
Dividend	68.00 (2.65%)
Ex-Dividend Date	Mar 30, 2026

Volume	154,000
Average Volume	272,370
Open	2,544.50
Previous Close	2,537.50
Day's Range	2,536.00 - 2,570.00
52-Week Range	1,897.00 - 2,597.50
Beta	-0.27
RSI	60.29
Earnings Date	Feb 10, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.